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Abstract  
Objectives: In Appalachia, tobacco smoking rates are significantly higher than the United States 
average, and many of the comorbidities that exist with tobacco are prominent. The researchers 
investigated the impact of tobacco smoking on patients for one year of health outcomes at our 
resident primary care clinic. 
Methods: The present study examined outpatient clinic charts and hospital records for a 
calendar year to determine patient self-reported tobacco rates. Patient medical comorbidities 
were tracked as well as rates of hospital utilization during the calendar year, and those figures 
were compared for a group of 90 patients who currently smoke and another group of 90 patients 
who have never smoked. 
Results: Tobacco smokers in the present study were more likely to have a history of several 
medical comorbidities including COPD, musculoskeletal problems, psychiatric treatment, and 
substance abuse issues. Additionally, tobacco smokers were more likely to have visited the 
emergency department and to have been admitted to the hospital during the year. 
Conclusions: The problem of tobacco smoking is complex and primary care clinics provide a 
wealth of information to investigate numerous comorbid concerns. Consistent with prior 
research, tobacco users in this study were at greater risk for many medical problems. 
Keywords 
tobacco, smoking, family medicine, primary care, hospital utilization, health outcomes 
Introduction 
Despite all that we know about smoking and the health risks, 17% of adults still smoke in the 
United States.  In West Virginia, where our resident clinic is located, the smoking rate is 27%, 
markedly higher than the national average.1 That rate makes West Virginia the highest smoking 
state in the United States and coincides with the second highest death rate for people due to 
smoking in the country. Further, while the adult smoking rate nationally has gradually declined, 
West Virginia data indicates that tobacco use has not tapered off significantly over the past 25 
years.1  
In a Morbidity and Mortality Weekly Report by the Centers for Disease Control it was found that 
smoking is the primary cause for at least 30% of all cancer deaths, nearly 80% of deaths due to 
COPD, and 33% of cardiovascular disease deaths in the USA.2 Thus, the risks of tobacco are 
numerous, diverse, and lethal.  Nicotine in tobacco causes coronary vasoconstriction, increased 
hypercoagulability, dyslipidemia and endothelial dysfunction. Smoking has been shown to be 
one of the major causes of numerous types of cancer. In smokers with a smoking related cancer, 
there are increased chances for getting a second smoking related malignancy.3 Nicotine in 
tobacco also effects insulin sensitivity, increasing the risk for developing type 2 diabetes 
mellitus.4 Smoking has also been found to accelerate bone loss and increase the risk for hip 
fracture, especially in women.5  
94
Marshall Journal of Medicine, Vol. 2 [2016], Iss. 3, Art. 12
https://mds.marshall.edu/mjm/vol2/iss3/12
DOI: http://dx.doi.org/10.18590/mjm.2016.vol2.iss3.12
 
 
In addition to the human toll, tobacco also takes a great deal of resources in regard to time and 
money. In the United States, smoking has served as a significant public health burden, 
particularly in the form of increased use of hospital services.6  The Centers for Disease Control 
and Prevention have estimated that smoking costs the United States $170 billion in direct 
medical expenses and $156 billion in lost productivity annually. 1  Smoking cigarettes has long 
been associated with the development of chronic medical illness culminating in high morbidity 
and mortality rates.  
A number of studies have displayed that cigarette smoking leads to an increased likelihood of 
hospitalization.7  Data from a selection of US Veterans Affairs outpatient clinics demonstrated 
that males who reported current or previous smoking on a screening questionnaire were at 
significantly increased risk of being hospitalized for a primary ambulatory care sensitive 
condition as compared to never smokers.7   Data also indicated that current smokers were at the 
highest risk of hospitalization when compared to previous smokers and never smokers. 
The aim of the present study is to investigate tobacco use variables in an Appalachian primary 
care resident clinic setting.  Prior research has provided a solid baseline for tobacco use in the 
United States.  To assess state-specific current cigarette smoking use among adults, the CDC 
analyzed data from the 2013 Behavioral Risk Factor Surveillance System (BRFSS). BRFSS is a 
state-based, telephone survey of non-institutionalized adults conducted annually in all 50 states 
and several US territories.   While the CDC report is very useful as a baseline measure, several 
limitations exist.   First, although most clinic patients today do have a telephone, BRFSS does 
not include adults without some type of telephone service.1   Second, estimates for current 
smoking prevalence are based on self-report and are not supplemented with medical records 
which can track smoking status over time at each appointment. Third, the median response rate 
for the 2013 BRFSS study was below 50% total which increases the potential for confounds due 
to non-response bias.    
Objectives 
The goal of the present study is to provide information regarding tobacco smoking rates, 
smoking comorbidities, and hospital utilization rates for smokers and never smokers in our 
resident primary care center.  The present study will involve electronic chart review where 
patients were specifically asked about current and past smoking during routine primary care 
medical visits. While it is common knowledge that smoking is harmful to health, this study aims 
to shed light on how smoking impacts outcomes for current smokers as compared to never 
smokers over a specified period of time (1 year) in a resident family medicine clinic.  As the 
resident clinic serves a large number of patients in an underserved area, there was particular 
interest in how outcomes might change in the course of the chart review.   
Methods 
Participants 
The records of 180 patient electronic health record (EHR) charts in a primary care resident clinic 
were reviewed.  In addition, the current smoker variable was assessed clinic wide to determine 
the overall current smoking rate among the 8,024 patients in the dataset.    
Inclusion Criteria 
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Retrospective chart review occurred for all family practice patients randomly selected who were:  
Adults, 18 and older as of March 1, 2012.   
Have been a patient in the medical center being studied for at least one year from start 
date of March 1, 2012 when EHR platform was available.   
Current smokers included in the study as indicated by answering current smoker question 
with “yes.” 
Never smokers included in the study as indicated by answering never smoked question 
with “yes.”  
Have been seen at least twice by primary care provider in the year of the study.   
Have had labs ordered at least twice within the year of the study so that outcomes could 
be compared after one year.   
Measures 
A Data Collection Sheet (see Appendix 1) was devised to organize and tabulate relevant variable 
values.  Variables were selected based on relevance to the study’s objectives and ease of 
availability in the clinic’s EHR.    
Appendix 1: Patient Data Collection Sheet 
1. Patient Number:  
2. Age:  
3. Gender: Male/Female 
4. Race/Ethnicity:  Caucasian/African American/Latino/Asian/other  
5. Smoker: Current/Former/Never Pack years:   
6. Chronic Obstructive Pulmonary Disease (COPD): 
7. Asthma:  
8. Systolic Coronary Heart Failure (CHF):  
9. Diastolic Coronary Heart Failure (CHF):  
10. Hypertension (HTN):  
11. Coronary Artery Disease (CAD):  
12. Hyperlipidemia (HLD):  
13. Peripheral Vascular Disease (PVD):  
14. Diabetes Mellitus Type 1 (DM-1): 
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15. Diabetes Mellitus Type 2 (DM-2): 
16. Cerebrovascular Accident (CVA): 
17. Cancer  
18. Psychiatric:  DSM DX:  Yes/No Specifics: Anxiety/Depression/ADHD/Bipolar Disorder/Other  
19. Substance Abuse: Yes/No Specifics:   
20. Hepatitis B:  
21. Hepatitis C: 
22. Gastro-esophageal Reflux Disorder (GERD) /gastritis:  
23. Musculoskeletal pain (MSK):  
24. Others:  
25. # ER visits (One Year):  
26. # Hospitalizations (One Year):  
27. Total Length of Stay: 
28. Total Surgeries (One Year):   
29. Total Cholesterol 1 (Chol-1): 
30. Total Cholesterol 2 (Chol-2): 
31. High Density Lipoprotein 1(HDL)-1:  
32. High Density Lipoprotein 2 (HDL)-2:  
33. Low Density Lipoprotein 1 (LDL-1):  
34. Low Density Lipoprotein 2 (LDL-2):  
35. Triglycerides – 1 (TG-1):  
36. Triglycerides – 2 (TG-2):  
37. Hemoglobin a1c-1:  
38. Hemoglobin a1c-2:  
39. Insulin:  
40. Oral Diabetes Mellitus Meds:  
41. #Anti-hypertensives:  
42. Antidepressants:  
43. Statins:  
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44. Benzodiazepines (BZD):  
45. Opiates:  
46. Smoking cessation counseling by provider: Yes/No Specifics:   
47. Offered smoking cessation assistance: Yes/ No  
48. Body Mass Index (BMI) Initial:  
49. Body Mass Index (BMI) Current: 
50. Obesity:  
51. Blood Pressure (BP) Initial:  
52. Blood Pressure (BP) Current:  
53. Pulse rate (PR Initial): 
54. Pulse Rate (PR Current):  
55. Oxygen (O2) saturation home:  
56. Oxygen (O2) saturation Initial:  
57. Oxygen (O2) later:  
58. #COPD exacerbations: 
DATA COLLECTION 
1. CAD: Any documentation of stenting, CABG, MI, Catheterization reports revealing CAD not 
requiring intervention 
2. HLD: Will follow ATP III guidelines, minimum interval between CHOL-1 and CHOL-2 to be 
6 month interval 
3. PVD: Documented imaging / documented arterial ulcer 
4. CVA: Medical imaging showing CVA/documentation 
5. Substance abuse: Other than smoking, will classify based on prevalence after documenting 
6. Obesity: As per documented BMI of 30 or greater  
7. Total surgeries:  This variable was omitted due to difficulty accurately tracking O/P surgeries 
in the year 
Procedures 
Records were reviewed by all of the investigators retrospectively for a full year for each patient 
who met the criteria for the study.  A power analysis using the G Power 3.1 program revealed 
that to achieve adequate power (Beta=.05) in the study’s MANOVAs, a sample of at least 88 
participants would be needed in each group.  Therefore, a sample of 90 current smokers and 90 
never smokers was obtained from a random list of patients.  Each patient had a unique record 
number that ensured that no person would be included in the study duplicitously.  The NextGen 
and Soarian electronic health record platforms were utilized to gather the data and SPSS was 
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used for analyses.    Patients were selected from a random numbers list for the analysis.  Patients 
who did not meet the inclusion criteria were excluded from the study.  The same procedure was 
used for both groups in the study until 90 patients were included in each group.       
Results 
A frequency analysis of clinic population data indicated an overall smoking rate of 38% among 
the 8,024 patients.  A random sample of 90 never smokers and 90 current smokers was further 
analyzed with several univariate and multivariate tests.  A p value of .05 was used in all analyses 
to determine significance.   
Table 1: Patient Demographic Descriptive Statistics 
______________________________________________________________________________ 
     Smoking Group  Never Smoker Group  
______________________________n   (%)________________     n__(%)__________________ 
Participants    90 (50)   90 (50) 
Gender 
Female   57 (63)   54 (60)  
Male    33 (37)   36 (40) 
Ethnicity 
 White    76 (84)   84 (93) 
 African-American  13 (14)   6    (7) 
 Latino    1    (1)    0    (0) 
Mental Health History  
* Psychiatric Diagnosis  70 (78)   54 (60) 
 ** Substance Abuse   16 (18)   2    (2) 
 
Age (years)    M      (SD)   M (SD) 
     55.2 (8.21)   55.6 (12.75) 
______________________________________________________________________________ 
Notes. * Chi square significant p < .01; ** Chi square significant p < .001. 
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Demographic data for the two groups is provided in Table 1.  Both groups were comprised of 
mostly female participants and were predominantly white in terms of ethnicity.  Age was not 
significantly different between the groups as both groups had a mean age of about 55 years.   Chi 
square analyses revealed significant differences in the prevalence of psychiatric diagnoses (p < 
.01) and substance abuse issues (p < .001) with the Smoking Group having higher rates of each. 
When looking exclusively at the Smoking Group (See Table 2), most patients did not receive 
formal tobacco treatment at the clinic, 77% were counseled by their physician regarding smoking 
and 99% were counseled by the medical assistant.   Finally, the Smoking Group had patients 
with a long history of tobacco use in terms of mean (M) pack years smoked (M = 31 pack years).  
Pack years refers to the number of packs of cigarettes a person smokes per day multiplied by the 
number of years smoked.   
______________________________________________________________________________ 
Table 2: Smoking Group Treatment Data 
______________________________________________________________________________ 
     Smoking Group  
      
n  (%)   
   
______________________________________________________________________________ 
  
 Counseled by medical assistant about tobacco use   89  (99) 
  
 Counseled by provider about tobacco use    69  (77) 
 
 Received tobacco treatment (NRT, medication)    7     (8) 
 
* Pack years smoked       M (SD) 
          31.2 (22.49) 
______________________________________________________________________________ 
Notes: n=90. * Pack Year Smoked Range 4-100; Pack year = packs per day smoked times years 
smoked. 
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Table 3 depicts comorbidity and resource utilization records within the year of treatment.  Chi 
square tests for nominal variables revealed significant differences in rates of COPD (p < .001) 
and musculoskeletal problems between the two groups (p < .01).  Patients in the Smoker Group 
demonstrated higher rates of both of those medical concerns. An Independent Samples t-test 
revealed significantly more medical comorbidities for the Smoking Group vs the Never Smoker 
groups (M=3.80 vs. 3.23; p < .05).  T-tests for hospital utilization data indicated that the 
Smoking Group utilized the emergency department significantly more (M = 1.47 vs. 0.67), and 
had a higher rate of hospital admissions (p < .05) when compared to the Never Smoker Group. In 
additions, the length of stay was more than a day more for the Smoker Group (M = 1.77 vs. 0.46) 
which was also significantly different, p < .05.  
Table 3: Group Comorbidities and Resource Utilization Data 
______________________________________________________________________________ 
      Smoking Group Never Smoker Group 
      n (%)  n (%) 
* COPD Diagnosis   36 (40)  2 (2) 
Asthma    11 (12)  17 (19)   
Hypertension    61 (68)  72 (80)  
Coronary Artery Disease  15 (17)  16 (18) 
Hyperlipidemia   50 (56)  54 (60) 
Peripheral Vascular Disease  5  (6)  3  (3) 
Diabetes Mellitus Type 2  31 (34)  33 (37) 
Cerebrovascular Accident  9 (10)  4  (4) 
Cancer     10 (11)  9 (10) 
GERD     47 (52)  37 (41)  
** Musculoskeletal Problems  67 (74)  44 (49) 
 
*** Total Number of Comorbidities  M (SD)        M  (SD) 
      3.80 (1.66)   3.23 (1.50) 
Resource Utilization Data  
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*** Emergency Dept Visits  1.47 (2.28)  0.67 (1.69) 
*** Hospital Admissions  0.70 (1.37)  0.28 (0.83) 
*** Hospital Days   1.77 (4.62)  0.46 (1.75) 
______________________________________________________________________________
Notes: * Chi square significant, p < .001; ** Chi square significant, p < .01; *** Independent 
Samples t-test significant, p < .05.  
Table 4 depicts one year outcomes for both groups.  A series of One Between One Within 
MANOVAs revealed several significant differences in repeated measures.  The Smoking Group 
had a healthier BMI than the Never Smoker Group (p < .001).  Conversely, the Never Smoker 
Group had healthier measures on pulse rate (p < .01) and HDL (p < .05) than their smoking 
counterparts.  The effect for time was significant in improving both cholesterol and LDL 
numbers for both smoking and nonsmoking groups (p < .01).  The interaction of time and 
tobacco group was significant for the cholesterol, HDL, and diastolic blood pressure variables.   
Cholesterol improved more among the Never Smokers over time (p < .01) while HDL improved 
more among the Current Smokers (p <.05).  Diastolic BP also improved over time more for the 
Current Smokers (p < .01) reaching the same level of the Never Smokers by the year’s end.   
______________________________________________________________________________ 
Table 4: Smoking and Never Smoker Group One Year Outcome Data   
______________________________________________________________________________ 
   Smoking Group   Never Smoker Group   
   Time 1      Time 2  Time 1    Time 2  
        M (SD)     M   (SD)  M  (SD)   M  (SD) 
______________________________________________________________________________ 
Repeated Measure 
a b Cholesterol  186.6  (47.7)    185.6  (55.4) 193.5 (41.9)    172.5  (37.7) 
c d HDL  45.6  (12.0)    46.4   (13.3) 51.5 (15.3)    49.0   (15.4) 
  a LDL   107.0  (32.0)    103.9  (39.1) 106.9 (38.9)    93.7   (33.0)  
Triglycerides  169.5   (119.5)   173.4  (128.3) 171.7 (79.6)    151.3   (81.9)  
HbA1c       7.1     (1.7)       7.1    (2.5)    6.9   (1.6)     6.9    (1.6) 
Systolic BP  131.1 (17.7)    128.7   (19.0) 129.2 (16.1)     130.0  (16.1) 
b Diastolic BP   79.7 (13.9)     76.6    (11.5) 75.6 (10.3)     76.6    (11.7) 
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e Pulse Rate   79.5 (15.1)     80.9    (14.6) 73.3 (13.2)     75.3    (15.1) 
f BMI    30.8  (8.0)     30.3    (8.3)  35.1  (9.3)     35.0     (9.3) 
O2 Saturation   97.3  (2.8)     96.8    (2.6)  97.6  (2.2)     97.5     (2.2) 
______________________________________________________________________________ 
Notes: One Between One Within MANOVA Results: (a) Effect for Time significant, p < .01;          
(b) Interaction significant, p < .01;  (c) Group difference significant, p < .05; (d) Interaction 
Significant, p < .05; (e) Group difference significant, p < .01; (f) Group difference significant, p 
< .001. 
Discussion 
The aim of this study was to examine tobacco use, comorbidities and hospital utilization rates 
among a sample of current smokers and never smokers in our resident Family Medicine clinic 
located in Appalachia.  The 38% tobacco smoking rate in the clinic was well above the national 
average of 17% for tobacco smoking.1  Chart records revealed all but one patient in the Smoking 
group was counseled by either the medical assistant or the doctor about tobacco cessation.  This 
is consistent with the present emphasis on tobacco assessment and tobacco treatment in clinics.   
Current trends to assess tobacco more frequently stand in contrast to a decade ago when patient 
tobacco use was not even addressed in many clinic visits.8  This would indicate that providers 
currently buy into the importance of assessing tobacco use in routine medical visits.  Moving 
forward, primary care clinics will continue to play an important role in identifying those with 
tobacco use disorders and aiding them in their efforts to quit.9   
Several findings in the present study pointed to the increased risk of other health problems 
related to smoking.  Consistent with prior work on bone density in females, current smokers had 
higher rates of musculoskeletal issues.5   Smoking reduces bone mineral content which puts 
patients at risk for osteoarthritis and fractures over time. Prior research has also shown that 
smoking has a negative influence on rheumatoid arthritis, intervertebral disc degeneration and 
ruptures.10  Research has long linked COPD to tobacco smoking.11  Well over a third of smokers 
in the present study had COPD and one per every six patients on average had reported a COPD 
exacerbation within the year.   
Findings on the link between substance abuse, psychiatric diagnoses, and tobacco smoke have 
been long documented as well, and this was a marked strong finding in the present study.12   
Prior research has indicated intrinsic (genetic), extrinsic (self-medication) and neuropathway 
(nicotine receptor) commonalities for those who use tobacco, those who use drugs/alcohol, and 
those who have longstanding psychiatric issues.13  Many primary care clinics nationwide now 
provide behavioral health services in an integrated care model treating tobacco use in the context 
of behavioral health issues.  This model can be quite helpful, especially in light of evidence that 
treatments such as nicotine replacement, medication, or focused counseling on tobacco cessation 
can improve quit rates threefold.8  
Not all of the outcomes pointed to better results for people who have never smoked.  One area 
where smokers had a healthier outcome was BMI, as smokers were lighter in weight by 4 BMI 
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points in comparison to their never smoker counterparts.  While BMI is one marker of health, 
research indicates that a non-smoker of similar height would need to be 100 pounds heavier to 
have the same health risks as compared to a smoker.14   The weight difference among the groups 
is consistent with prior research linking nicotine to appetite suppression and lowered body 
weight.15  
The US Centers for Disease Control has highlighted the negative impact of tobacco smoking on 
dyslipidemia and cardiovascular functioning.2   Repeated measures over the year of study 
indicated better outcomes in lipid measures (cholesterol, LDL) for both groups.  However, never 
smokers showed more improvement in cholesterol levels throughout the year of the study.   
Interestingly, while HDL levels were healthier for never smokers, current smokers demonstrated 
more improvement in HDL levels in the year of study.  While this could be explained by another 
confounding factor,  there is also the likelihood that the smoker group had more room for 
improvement through the course of the year in HDL levels since they had lower levels of HDL 
from the onset.   Regarding cardiovascular variables, patients in the Current Smoker Group were 
able to improve diastolic blood pressure over time while never smokers did not.  In fact, diastolic 
blood pressure at the end of the study was the same in both groups.    
Emergency department (ED) visits and hospital stays can be costly and cumbersome for patients.    
At first glance, a difference between the two groups of nearly one ED visit and one day in the 
hospital may not appear to be clinically significant.  However, if these figures are extrapolated 
10 years into the future, that projects to 10 extra ED visits and 10 extra hospital days per smoker.   
These higher utilization rates are consistent with prior studies and point to the importance of 
tobacco cessation early in patient lives prior to health conditions necessitating greater hospital 
utilization.7,16  
The present study was not without limitations.  First, one concern is the accuracy of self-report in 
regard to tobacco smoking.  This is a potential issue in virtually every study about tobacco use 
but should be negated somewhat by the present chart review strategy.  Second, another limitation 
of the study was the amount of time patient chart data was collected.   The impact of tobacco use 
is best studied long term, but the clinic in the present study had only made use of the electronic 
health record (EHR) platform for a little more than one year.  Future studies will enable tracking 
of tobacco use and comorbidities for longer periods of time as the same EHR platform is utilized.       
Conclusions 
Future directions for tobacco research should continue to investigate patients in primary care 
clinics and the impact that smoking has on wellness and subsequent treatment. Smoking rates 
impacted  medical comorbidities and hospital utilization rates in the present study and this all 
pointed to a continued need for tobacco assessment and cessation services.  Strong consideration 
of behavioral health treatment could also help the high percentage of people who have comorbid 
addiction and psychiatric issues.  The treatment of tobacco use in primary care has the potential 
to prevent numerous future health concerns, but only if providers are vigilant and patients are 
willing to work on a shared goal of cessation.          
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